Status:

TERMINATED

A Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) on Healing Time of Distal Radius Fractures

Lead Sponsor:

Amorphical Ltd.

Conditions:

Distal Radius Fractures

Eligibility:

All Genders

50-90 years

Phase:

PHASE1

PHASE2

Brief Summary

Amorphical has a strong basis to believe that the Amorphous Calcium Carbonate (ACC) product has an effect on active mineralization during bone remodelling hence, it has a potential to accelerate fract...

Detailed Description

Eligible subjects will be treated as follows: Fifty (50) subjects will be randomly assigned to one of two groups (N=25). Subjects in the treatment group will receive amorphous calcium carbonate (ACC)...

Eligibility Criteria

Inclusion

  • Subjects with closed unilateral dorsally angulated fracture of the distal radius (Colles') visible by x-ray.
  • Subjects that can begin taking the study treatment exactly 7 (+1) days from the fracture event.
  • Subjects treated conservatively by closed reduction and immobilization
  • Age 50-90 (inclusive)
  • Subjects able to adhere to the visit schedule and protocol requirements and be available to complete the study.
  • Subject that had signed the ICF.

Exclusion

  • Subjects with intra articular fracture or extra-articular fracture that meets the criteria for operative fracture fixation.
  • Subjects with pins or plates in the wrist
  • Sustained previous fractures or bone surgery in the currently fractured distal forearm
  • Subjects with multiple trauma (several fractures at once)
  • Subjects suffering from joint diseases that affect the function of the wrist and/or hand of the injured arm.
  • Elevated serum calcium (\> 10.2 mg/dL)
  • 25-hydroxyvitamin D \< 20 ng/mL
  • Subjects suffering from active liver disease or clinical jaundice
  • Subjects with current or a history of a malignant neoplasm in the 5 years prior to the study
  • Cognitive impairment

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2015

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT01859468

Start Date

June 1 2013

End Date

February 1 2015

Last Update

August 4 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Bazilai Medical Center

Ashkelon, Israel, 78278

2

Barzilai Medical Center

Ashkelon, Israel